3-Methylcrotonyl-CoA carboxylase deficiency

3-Methylcrotonyl-CoA carboxylase deficiency
3-Methylcrotonyl-CoA carboxylase deficiency
Classification and external resources

Methylcrotonyl-CoA
OMIM 210200 210210
DiseasesDB 32207

3-Methylcrotonyl-CoA carboxylase deficiency (3MCC deficiency), also known as 3-Methylcrotonylglycinuria or BMCC deficiency is an inherited disorder in which the body is unable to process certain proteins properly. People with this disorder have inadequate levels of an enzyme that helps break down proteins containing the amino acid leucine. This condition affects an estimated 1 in 50,000 individuals worldwide.

Contents

Presentation

Infants with this disorder appear normal at birth but usually develop signs and symptoms during the first year of life or in early childhood. The characteristic features of this condition, which can range from mild to life-threatening, include feeding difficulties, recurrent episodes of vomiting and diarrhea, excessive tiredness (lethargy), and weak muscle tone (hypotonia). If untreated, this disorder can lead to delayed development, seizures, and coma. Early detection and lifelong management (following a low-protein diet and using appropriate supplements) may prevent many of these complications. In some cases, people with gene mutations that cause 3-methylcrotonyl-CoA carboxylase deficiency never experience any signs or symptoms of the disorder.

The characteristic features of this condition are similar to those of Reye syndrome, a severe disorder that develops in children while they appear to be recovering from viral infections such as chicken pox or flu. Most cases of Reye syndrome are associated with the use of aspirin during these viral infections.

Treatment

Symptoms can be reduced through avoidance of leucine, an amino acid. Leucine is a component of most protein-rich foods; therefore, a low-protein diet is recommended. Some isolated cases of this disorder have responded to supplemental biotin;[1] this is not altogether surprising, consider that other biotin-related genetic disorders (such as biotinidase deficiency and holocarboxylase synthetase deficiency) can be treated solely with biotin. Individuals with these multiple carboxylase disorders have the same problem with leucine catabolism as those with 3-methylcrotonyl-CoA carboxylase deficiency.

Genetics

The MCCC1 and MCCC2 genes make protein subunits that come together to form an enzyme called 3-methylcrotonyl-CoA carboxylase. This enzyme plays an essential role in breaking down proteins from the diet. Specifically, the enzyme is responsible for the fourth step in processing leucine. If a mutation in the MCCC1 or MCCC2 gene reduces or eliminates the activity of 3-methylcrotonyl-CoA carboxylase, the body is unable to process leucine properly. As a result, toxic byproducts of leucine processing build up to harmful levels, damaging the brain and nervous system. This condition is inherited in an autosomal recessive pattern.

Screening

It is one of the 29 conditions currently recommended for newborn screening by the American College of Medical Genetics.

References

This article incorporates public domain text from The U.S. National Library of Medicine

  1. ^ Baumgartner, Matthias R.; Dantas, M.Fernanda; Suormala, Terttu; Almashanu, Shlomo; Giunta, Cecilia; Friebel, Dolores; Gebhardt, Boris; Fowler, Brian et al. (2004). "Isolated 3-Methylcrotonyl-CoA Carboxylase Deficiency: Evidence for an Allele-Specific Dominant Negative Effect and Responsiveness to Biotin Therapy". The American Journal of Human Genetics 75 (5): 790–800. doi:10.1086/425181. PMC 1182108. PMID 15359379. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1182108. 

External links


Wikimedia Foundation. 2010.

Игры ⚽ Поможем написать курсовую

Look at other dictionaries:

  • 3-methylcrotonyl CoA carboxylase deficiency — 3 meth·yl·cro·to·nyl CoA car·box·y·lase de·fi·cien·cy (meth″əl kroґtə nil″ ko aґ kahr bokґsə lās) an autosomal recessive aminoacidopathy due to deficiency of methylcrotonoyl CoA carboxylase, which can result from… …   Medical dictionary

  • Methylcrotonyl-CoA-Carboxylase — Methylcrotonoyl CoA Carboxylase 1 (α Untereinheit) Größe 725 AA Kofaktor Biotin Bezeichner …   Deutsch Wikipedia

  • Methylcrotonyl-CoA carboxylase — methylcrotonoyl Coenzyme A carboxylase 1 (alpha) Identifiers Symbol MCCC1 Entrez 56922 HUGO …   Wikipedia

  • Methylcrotonoyl-CoA-Carboxylase — 1 (α Untereinheit) Masse/Länge Primärstruktur 725 AA …   Deutsch Wikipedia

  • Methylmalonyl-CoA mutase deficiency — Classification and external resources OMIM 251000 DiseasesDB 29509 Methylmalonyl CoA mutase deficiency ( MUT ) is an inborn error of organ …   Wikipedia

  • Propionyl-CoA carboxylase — PCCA redirects here. For other uses, see PCCA (disambiguation). Propionyl CoA carboxylase Identifiers EC number 6.4.1.3 CAS number …   Wikipedia

  • methylcrotonoyl-CoA carboxylase — meth·yl·cro·ton·o·yl CoA car·box·y·lase (meth″əl kro tonґo əl ko aґ kahr bokґsə lās) [EC 6.4.1.4] a biotin containing enzyme of the ligase class that catalyzes the ATP driven carboxylation of 1. 3 methylcrotonyl CoA to… …   Medical dictionary

  • 3-methylcrotonyl-CoA — An intermediate in the degradation of l leucine; accumulates in a deficiency of M. carboxylase. 3 methylcrotonyl CoA carboxylase a biotin dependent enzyme in the pathway of l leucine degradation that catalyzes the reaction of M. with CO2, ATP,… …   Medical dictionary

  • Ornithine transcarbamylase deficiency — Classification and external resources Ornithine ICD 10 E …   Wikipedia

  • Beta-ketothiolase deficiency — Classification and external resources Isoleucine OMIM 203750 …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”